- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/04 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 263/04
Total number of patents in this class: 89
10-year publication summary
|
3
|
3
|
8
|
5
|
4
|
7
|
2
|
5
|
4
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Johns Hopkins University | 5887 |
4 |
| Instituto Mexicano Del Petroleo | 201 |
4 |
| National Institute of Biological Sciences, Beijing | 101 |
4 |
| Ústav organické chemie a biochemie AV {hacek over (C)}R, v.v.i. | 6 |
4 |
| Advancion Corporation | 122 |
4 |
| Dong-A ST Co., Ltd. | 139 |
3 |
| Allergan, Inc. | 2162 |
2 |
| Chiesi Farmaceutici S.p.A. | 960 |
2 |
| FMC Corporation | 806 |
2 |
| Ligand Pharmaceuticals Incorporated | 168 |
2 |
| Neuropro Therapeutics, Inc. | 22 |
2 |
| Sun Pharmaceutical Industries Inc | 232 |
2 |
| Gotion Inc. | 39 |
2 |
| Dracen Pharmaceuticals, Inc. | 11 |
2 |
| NanoVation Therapeutics Inc. | 88 |
2 |
| The Procter & Gamble Company | 21849 |
1 |
| Bristol-myers Squibb Company | 4751 |
1 |
| The Regents of the University of California | 20778 |
1 |
| Genentech, Inc. | 4110 |
1 |
| Merck Patent GmbH | 5729 |
1 |
| Other owners | 43 |